Danahy Kevin Patrick Insider Trading Activity

Average Profitability
71.09%
Insider Buys Quantity
2
Insider Buys Sum
$50,105.64
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Danahy Kevin Patrick

According to the SEC Form 4 filings, Danahy Kevin Patrick, being in a position of

  1. Chief Commercial Officer at Pulse Biosciences, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 125000 shares for $2.93M,
    over all time since 2022-09-30, has bought 11893 shares for $50,106, and sold 150000 shares for $3.39M.

Biography of Danahy Kevin Patrick

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$2,932,2007100

Comparison of Insiders on Amount of Buys and Sells

2026-02-18SalePulse Biosciences, Inc.
PLSE
Chief Commercial Officer
5,000
0.0069%
$23.64$118,200+5.81%
2026-02-17SalePulse Biosciences, Inc.
PLSE
Chief Commercial Officer
20,000
0.0295%
$23.63$472,600+13.71%
2026-02-13SalePulse Biosciences, Inc.
PLSE
Chief Commercial Officer
20,000
0.0302%
$23.53$470,600+16.86%
2026-02-12SalePulse Biosciences, Inc.
PLSE
Chief Commercial Officer
20,000
0.0295%
$23.37$467,400+13.7%
2026-02-11SalePulse Biosciences, Inc.
PLSE
Chief Commercial Officer
20,000
0.0295%
$25.20$504,000+4.24%
2026-02-10SalePulse Biosciences, Inc.
PLSE
Chief Commercial Officer
20,000
0.029%
$23.52$470,400+9.97%
2026-02-09SalePulse Biosciences, Inc.
PLSE
Chief Commercial Officer
20,000
0.0261%
$21.45$429,000+8.59%
2025-10-02SalePulse Biosciences, Inc.
PLSE
Chief Commercial Officer
4,600
0.0072%
$18.53$85,238+13.69%
2025-09-19SalePulse Biosciences, Inc.
PLSE
Chief Commercial Officer
400
0.0006%
$18.48$7,392+17.32%
2025-09-18SalePulse Biosciences, Inc.
PLSE
Chief Commercial Officer
20,000
0.0297%
$18.49$369,800+11.07%
2023-11-16PurchasePulse Biosciences, Inc.
PLSE
Chief Executive Officer
5,393
0.0102%
$6.52$35,156+78.04%
2022-09-30PurchasePulse Biosciences, Inc.
PLSE
Chief Executive Officer
6,500
0.0192%
$2.30$14,950+64.13%
Total: 12
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.